A new and potentially revolutionary drug was just approved by the FDA. The drug is Degarelix and is made by Ferring Pharmaceuticals. This new drug will help with the treatment of advanced forms of prostate cancer. This new drug could not only help improve and save the lives of prostate cancer but it is possible that Degarelix could be a stepping stone to help make more other drugs that could help to fight other diseases as well. To learn how Degarelix could be some new super drug like a more modern penicillin you have to know the history of the development of Degarelix and how it works, to do that you will have to read on.
Degarelix just finished its testing on patients. What they found while testing patients was that not only was Degarelix more effective against prostate cancer but the reason why it might be better at fighting prostate cancer was surprising and offered great possibilities. The first results of the drug test were positive as would be expected for a promising new drug. The trial was a random trial but those that used Degarelix showed that the drug was able to suppress testosterone which helps feed the cancer better then other current drugs on the market. Besides the suppression of testosterone which is what you want to see when battling prostate cancer test also showed a more important drop in what are known as prostate-specific antigens which is a fancy way of saying prostate cancer showing that it was in fact working. Not only did Degarelix work faster, it also worked more effectively with fewer side effects then current prostate cancer drugs.
While this is clearly good news for all of us men and good to know that we now have an extremely effective drug in the fight against prostate cancer that alone does not make Degarelix a super drug that could help fight many other diseases as well. The reason that Degarelix could help make new drugs for other problems is that it appears that the drug itself may not be the only thing that is helping with the healing process but that it may in fact be helping the bodies immune system to fight the cancer. If Degarelix can help the immune system better fight prostate cancer it might be able to get the immune system to fight other things. A derivative of Degarelix for example may fight another form of cancer. So far it is only a possibility but as Degarelix has been approved and soon will be marketed it is likely that Ferring Pharmaceuticals will be able to look into other drug possibilities.
Clearly any new developments will take years before they will be able to help others but we do have hope that new drugs may be made which will support our own immune systems in the fight against disease. At the very least Degarelix offers a new and improved drug in the fight against prostate cancer.